{"id":"W2041349698","doi":"10.1586/14779072.2014.938055","title":"Oral anticoagulant use in addition to antiplatelet therapy for secondary prevention in acute coronary syndrome: current perspectives","year":2014,"lang":"en","type":"review","venue":"Expert Review of Cardiovascular Therapy","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Rivaroxaban; Acute coronary syndrome; TIMI; Clopidogrel; Internal medicine; P2Y12; Cardiology; Platelet aggregation inhibitor; Prasugrel; Secondary prevention; Aspirin; Warfarin; Myocardial infarction; Percutaneous coronary intervention; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001046718,0.0007523169,0.002291061,0.002222956,0.0002057869,0.001100258,0.001019616,0.00116118,0.004921903],"category_scores_gemma":[0.001286742,0.000263783,0.001124286,0.002547301,0.000374828,0.001118618,0.0005673484,0.001455549,0.001258938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004438277,"about_ca_system_score_gemma":0.001251665,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001342276,"about_ca_topic_score_gemma":0.00325755,"domain_scores_codex":[0.9996126,0.00009373633,0.00008871003,0.00005299867,0.0001274993,0.00002449335],"domain_scores_gemma":[0.999181,0.0004537181,0.0001501797,0.00001255919,0.0001684116,0.00003406668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001218169,0.00008845472,0.0002273083,0.06670088,0.0003774221,0.0001510683,0.00005561473,0.0001837241,0.0005253674,0.001900653,0.02043943,0.9092283],"study_design_scores_gemma":[0.0001620831,0.0003322144,0.002602543,0.06001273,0.001899955,0.002580336,0.0001880385,0.0002320815,0.0003141748,0.003292095,0.9283343,0.00004947226],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004511079,0.9994475,0.0000232593,0.0001787018,0.00007071553,0.000002370058,0.000007565251,0.000001625904,0.0002230163],"genre_scores_gemma":[0.0003144132,0.9993696,0.00005273996,0.00009891318,0.00008271098,0.00000266136,0.00000889085,3.892314e-7,0.00006970943],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004921903,"threshold_uncertainty_score":0.01646543,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1087515911970197,"score_gpt":0.4210028351994481,"score_spread":0.3122512440024285,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}